WILLIAMS SONOMA INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data WILLIAMS SONOMA INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	5,084	5,292	5,672	5,898	6,783	8,246	8,674	7,751	7,712	7,807
Cost of revenue								4,447	4,129	4,204
Gross profit	1,883	1,932	2,101	2,139	2,636	3,632	3,678	3,304	3,582	3,603
Selling, general and administrative	1,411	1,478	1,665	1,673	1,726	2,179	2,179	2,059	2,152	2,187
Operating income	473	454	436	466	911	1,453	1,498	1,244	1,430	1,416
Pre-tax income	472	452	429	457	894	1,451	1,501	1,273	1,486	1,453
Income tax	167	193	95.6	101	214	325	373	324	360	364
Net income	305	260	334	356	681	1,126	1,128	950	1,125	1,088
EBITDA	646	637	625	654	1,099	1,649	1,713	1,477	1,660	1,647
EPS, basic	1.73	1.52	2.05	2.28	4.41	7.59	8.29	7.35	8.91	8.96
EPS, diluted	1.71	1.51	2.03	2.25	4.31	7.38	8.16	7.28	8.79	8.84
Shares, basic (weighted)	177	171	163	156	155	149	136	129	126	121
Shares, diluted (weighted)	179	172	165	158	158	153	138	131	128	123
Dividend per share	0.74	0.78	0.86	0.96	1.01	1.30	1.56	1.80	2.28	2.64

Balance sheet

	FY2016	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	214	390	339	432	1,200	850	367	1,262	1,213	1,020
Receivables	88.8	90.1	107	112	144	132	116	123	118	127
Inventory	978	1,062	1,125	1,101	1,006	1,246	1,456	1,246	1,332	1,463
Other current assets	10.7	11.9	21.9	20.8	22.9	26.2	32	29	24.6	23.7
Total current assets	1,367	1,636	1,694	1,756	2,467	2,324	2,036	2,720	2,755	2,713
Property, plant and equipment	923	932	930	929	874	921	1,065	1,013	1,034	1,095
Lease right-of-use assets				1,166	1,086	1,133	1,286	1,230	1,178	1,270
Goodwill	18.7	18.8	85.4	85.3	85.4	85.4	77.3	77.3	77.3	77.4
Other non-current assets	51.2	131	59.4	69.7	87.1	106	116	123	137	157
Total assets	2,477	2,786	2,813	4,054	4,661	4,626	4,663	5,274	5,302	5,412
Accounts payable	454	457	527	521	543	613	508	608	646	638
Accrued liabilities	130	134	164	175	268	320	248	264	286	315
Deferred revenue					373	448	479	574	585	603
Short-term debt				300	299	0
Total current liabilities	961	1,008	1,075	1,610	1,848	1,772	1,636	1,880	1,912	1,954
Long-term debt		299	300		0
Lease liabilities				1,095	1,025	1,067	1,212	1,156	1,113	1,236
Other non-current liabilities	71.2	72.8	81.3	86.4	117	107	114	109	134	140
Total liabilities	1,229	1,582	1,657	2,818	3,010	2,961	2,962	3,146	3,159	3,329
Total debt		299	300	300	299	0
Paid-in capital	557	563	582	606	638	601	573	588	572	587
Retained earnings	702	647	584	645	1,020	1,074	1,142	1,556	1,592	1,509
Treasury stock	-1.38	-0.73	-0.24	-0.94	-0.6	-0.71	-0.7	-1.4	-0.4	-2.02
Other comprehensive income	-9.9	-6.78	-11.1	-14.6	-7.12	-10.8	-13.8	-15.6	-21.6	-13.2
Shareholders' equity	1,248	1,204	1,156	1,236	1,651	1,664	1,701	2,128	2,142	2,083
Total equity	1,248	1,204	1,156	1,236	1,651	1,664	1,701	2,128	2,142	2,083
Total liabilities and equity	2,477	2,786	2,813	4,054	4,661	4,626	4,663	5,274	5,302	5,412
Shares outstanding	175	167	0.16	154	153	144	66.2	128	123	119

Cash flow statement

	FY2016	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	305	260	334	356	681	1,126	1,128	950	1,125	1,088
Depreciation and amortization	173	183	189	188	189	196	214	233	230	231
Stock-based compensation	51.1	43	59.8	64.2	73.2	95.2	90.3	84.8	99	107
Deferred income tax	7.11	63.4	23.6	-2.56	-13.1	2.54	-23.8	-29.1	-9.74	20.3
Change in inventory	4.49	-80.2	-70.3	24.2	99.1	-240	-209	209	-88.1	-126
Change in payables	4.28	2.55	62.4	-11.1	25.5	56.7	-114	99	15.4	-31.8
Cash from operations	525	500	586	607	1,275	1,371	1,053	1,680	1,360	1,315
Capital expenditures	-197	-190	-190	-186	-170	-227	-354	-188	-222	-259
Acquisitions		-80.5	0
Cash from investing	-197	-270	-188	-186	-169	-226	-354	-188	-221	-261
Debt issued		300	0
Debt repaid				0	0	-300	0	0
Stock issued	1.53	0	0
Share buybacks	-151	-196	-295	-149	-150	-899	-880	-313	-807	-854
Dividends paid	-134	-135	-140	-151	-158	-188	-217	-232	-280	-316
Cash from financing	-306	-51.7	-450	-327	-343	-1,492	-1,179	-598	-1,184	-1,252
Exchange rate effect	-1.86	-1.81	0.8	-1.31	5.23	-2.91	-3.19	0.95	-3.82	4.88
Net change in cash	20.1	176	-51.2	93.2	768	-350	-483	895	-49	-193
Free cash flow	327	310	396	421	1,105	1,145	699	1,492	1,139	1,055
Interest paid	2.2	2.92	11.4	12.7	18.3	3.09	0.79	0.84	0.85	0.69
Income taxes paid	203	99.1	108	113	163	306	401	316	399	330

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 2, 2026; growth uses fiscal years. Valuation uses the share price of $231.90 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	47.2%	Gross profit / revenue.
Operating margin	19.2%	Operating income / revenue.
EBITDA margin	22.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	19.7%	Pre-tax income / revenue.
Net margin	14.7%	Net income / revenue.
FCF margin	16.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.1%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	55.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	21.4%	Net income / average total assets.
Return on invested capital (ROIC)	103.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	28.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.3%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-3.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-1.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-1.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	9.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-1.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	8.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-3.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	0.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	2.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-3.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	7.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	0.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-7.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	14.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-0.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	15.8%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	19.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	21.2%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-2.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	3.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.45x	Current assets / current liabilities.
Quick ratio	0.62x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.54x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	61.1%	Total liabilities / total assets.
Working capital	$848.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.06B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.45x	Revenue / average total assets.
Fixed asset turnover	7.14x	Revenue / average property, plant and equipment.
Inventory turnover	2.92x	Cost of revenue / average inventory.
Days inventory	125 days	365 x average inventory / cost of revenue.
Receivables turnover	54.7x	Revenue / average receivables.
Days sales outstanding	7 days	365 x average receivables / revenue.
Days payables	61 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	71 days	Days inventory + days sales outstanding - days payables.
FCF conversion	113.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$9.92	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$67.33	Revenue / diluted weighted shares.
FCF per share	$11.30	Free cash flow / diluted weighted shares.
Operating cash flow per share	$13.53	Cash from operations / diluted weighted shares.
Book value per share	$18.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$17.52	Tangible book value / shares outstanding.
Cash per share	$8.74	(Cash + short-term investments) / shares outstanding.
Payout ratio	28.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	25.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	63.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$27.31B	Share price x shares outstanding.
Enterprise value	$26.28B	Market cap + total debt - cash - short-term investments.
P/E	23.2x	Market cap / net income. Only when net income is positive.
P/S	3.41x	Market cap / revenue.
P/B	12.8x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	13.2x	Market cap / tangible book value, when positive.
P/FCF	20.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	17.0x	Market cap / cash from operations, when positive.
EV/Sales	3.28x	Enterprise value / revenue.
EV/EBIT	17.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.9%	Free cash flow / market cap.
Earnings yield	4.3%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	4.4%	(Dividends paid + share buybacks) / market cap.
PEG	8.56x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was WILLIAMS SONOMA INC's revenue in fiscal 2025?

WILLIAMS SONOMA INC reported revenue of $7.81B for fiscal 2025, 1.2% higher than the year before.

Was WILLIAMS SONOMA INC profitable in fiscal 2025?

Yes. Net income was $1.09B, a net margin of 13.9%.

How much free cash flow did WILLIAMS SONOMA INC generate in fiscal 2025?

Cash from operations of $1.31B minus capital expenditures of $259.4M left free cash flow of $1.06B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to WILLIAMS SONOMA INC